METTL14-mediated methylation of SLC25A3 mitigates mitochondrial damage in osteoblasts, leading to the improvement of osteoporosis
Experimental Gerontology · 2024
DOI: 10.1016/j.exger.2024.112496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Gerontology, 2024. Verfasst von Ping Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Anhui Medical University, Department of Endocrinology, Hefei, Anhui 230000, China; Anhui No.2 Provincial People's Ho…. Hauptthemen laut MEDLINE: Cell Differentiation, Methyltransferases, Mitochondria, Osteoblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Anhui Province Department of Education, Anhui Provincial Natural Science Foundation, Anhui Department of Human Resources and Social Security.
Abstract (Originalsprache)
PURPOSE: Osteoporosis is linked to impaired function of osteoblasts, and decreased expression of METTL14 may result in abnormal differentiation of these bone-forming cells. However, the specific impact of METTL14 on osteoblast differentiation and its underlying mechanisms are not yet fully understood. METHODS AND RESULTS: This study discovered a positive correlation between METTL14 expression and bone formation in specimens from osteoporosis patients and ovariectomized (OVX) mice. Additionally, METTL14 targeting of SLC25A3 contributed to the restoration of mitochondrial ROS levels and mitochondrial membrane potential in osteoblasts and promoted osteoblast differentiation. Moreover, in vivo experiments showed that METTL14 enhanced bone formation, and therapeutic introduction of METTL14 countered the decrease in bone formation in OVX mice. CONCLUSIONS: Overall, these findings emphasize the crucial role of the METTL14/SLC25A3 signaling axis in osteoblast activity, suggesting that this axis could be a potential target for improving osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Anhui Medical University, Department of Endocrinology, Hefei, Anhui 230000, China; Anhui No.2 Provincial People's Hospital, Department of Endocrinology, Hefei, Anhui 230000, China.
- Anhui Medical College, Department of Clinical Medicine, Hefei, Anhui 230000, China.
- The First Affiliated Hospital of Anhui Medical University, Department of Endocrinology, Hefei, Anhui 230000, China.
- The First Affiliated Hospital of Anhui Medical University, Department of Endocrinology, Hefei, Anhui 230000, China. Electronic address: zhangqiu@ahmu.edu.cn.
- The First Affiliated Hospital of Anhui Medical University, Department of Endocrinology, Hefei, Anhui 230000, China. Electronic address: chenyiqing0107@163.com.
- The First Affiliated Hospital of Anhui Medical University, Department of Endocrinology, Hefei, Anhui 230000, China. Electronic address: drzhangnan@126.com.
Förderung
- Anhui Province Department of Education
- Anhui Provincial Natural Science Foundation
- Anhui Department of Human Resources and Social Security
Zitieren
APA
Wang, P., Zhou, W., Chen, F., Zhang, X., Zhang, Q., Chen, Y., & Zhang, N. (2024). METTL14-mediated methylation of SLC25A3 mitigates mitochondrial damage in osteoblasts, leading to the improvement of osteoporosis. Experimental Gerontology. https://doi.org/10.1016/j.exger.2024.112496
Vancouver
Wang P, Zhou W, Chen F, Zhang X, Zhang Q, Chen Y, et al. METTL14-mediated methylation of SLC25A3 mitigates mitochondrial damage in osteoblasts, leading to the improvement of osteoporosis. Experimental Gerontology. 2024. doi:10.1016/j.exger.2024.112496
BibTeX
@article{Wang2024,
author = {Wang, Ping and Zhou, Weifeng and Chen, Fuhua and Zhang, Xiaoping and Zhang, Qiu and Chen, Yiqing and Zhang, Nan},
title = {METTL14-mediated methylation of SLC25A3 mitigates mitochondrial damage in osteoblasts, leading to the improvement of osteoporosis},
journal = {Experimental Gerontology},
year = {2024},
doi = {10.1016/j.exger.2024.112496}
}
EUVIMED